Skip to main content
AIDS 2026, the 26th International AIDS Conference

Press conference programme

AIDS 2026 will be a hybrid conference, taking place in Rio de Janeiro, Brazil, and virtually on 26-31 July 2026. All press conferences will be accessible virtually. 

alternative text

Press releases will be issued at the start of each press conference. Please note that each press conference has a unique registration link that will be uploaded below or through the virtual media platform. 

All media are required to register for the conference. For more information, please visit the media registration webpage.

Tuesday, 14 July

Embargoed press briefing

Time: 16:00 – 17:00 CEST 

Format: Virtual

Tuesday, 21 July

Scientific highlights press conference

Read the press release here

Time: 11:00 – 12:00 BRT / 16:00 – 17:00 CEST

Format: Virtual

Speakers:

  • Beatriz Grinsztejn, IAS President and AIDS 2026 International Co-Chair, Rio de Janeiro, Brazil
  • Elise Lankiewicz, amfAR, The Foundation for AIDS Research, Washington DC, USA
    Measuring PEPFAR disruptions at scale: Results from a 46-country implementing partner survey
  • Ramona Godbole, Heidelberg Institute of Global Health, Heidelberg, Germany
    Shifts in PEPFAR-supported pediatric treatment: rapid analysis of fiscal year 2025 PEPFAR program data
  • Noah Kiwanuka, Makerere University School of Public Health, Kampala, Uganda
    Zero HIV acquisitions with twice-yearly subcutaneous lenacapavir for PrEP during 52 weeks of open-label extension in PURPOSE 1
  • Marcelo Losso, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina
    High efficacy of twice-yearly subcutaneous lenacapavir for PrEP through 52 weeks of open-label extension in PURPOSE 2
  • Amy Colson, Cambridge Health Alliance, Cambridge, MA, USA
    Weekly oral islatravir and lenacapavir for the treatment of HIV-1 infection: Week 48 results of the Phase 3 ISLEND-1 and ISLEND-2 trials.
  • Shalena Naidoo, Stellenbosch University, Biomedical Sciences, Cape Town, South Africa
    Plasma viral suppression does not ensure CNS immunological quiescence in early-treated adolescents with perinatally acquired HIV

Monday, 27 July

Opening press conference

Time: 14:00 – 15:00 BRT

Format: In person & virtual

Location: Press conference room (Room 211, Riocentro Convention & Event Center)

Registration: Register and join here

Speakers:

  • Beatriz Grinsztejn, IAS President and AIDS 2026 International Co-Chair, Rio de Janeiro, Brazil
  • Winnie Byanyima, Executive Director of UNAIDS and Under-Secretary-General of the United Nations, Geneva, Switzerland
  • Other high-level speakers to be confirmed.

 

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.